Citizens Business Bank Biomarin Pharmaceutical Inc Transaction History

Citizens Business Bank

$476 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 18, 2022	SELL	$71.48 - $86.85 $10,293 - $12,506	-144 Reduced 1.76%	8,053 $667,000
Q2 2021 Nov 18, 2022	BUY	$75.51 - $84.79 $261,944 - $294,136	3,469 Added 73.37%	8,197 $684,000
Q1 2021 Nov 18, 2022	SELL	$74.73 - $90.69 $1.4 Million - $1.7 Million	-18,742 Reduced 79.86%	4,728 $357,000
Q4 2020 Nov 18, 2022	SELL	$72.61 - $90.2 $1.12 Million - $1.39 Million	-15,459 Reduced 39.71%	23,470 $2.06 Million
Q3 2020 Nov 18, 2022	BUY	$71.87 - $131.03 $67,701 - $123,430	942 Added 2.48%	38,929 $2.96 Million
Q2 2020 Nov 18, 2022	SELL	$79.55 - $124.22 $37,308 - $58,259	-469 Reduced 1.22%	37,987 $4.69 Million
Q1 2020 Nov 18, 2022	BUY	$71.37 - $96.85 $15,630 - $21,210	219 Added 0.57%	38,456 $3.25 Million
Q4 2019 Nov 18, 2022	BUY	$64.27 - $86.37 $837,438 - $1.13 Million	13,030 Added 51.69%	38,237 $3.23 Million
Q3 2019 Nov 18, 2022	SELL	$67.4 - $85.11 $21,568 - $27,235	-320 Reduced 1.25%	25,207 $1.7 Million
Q2 2019 Nov 18, 2022	SELL	$80.35 - $93.9 $75,850 - $88,641	-944 Reduced 3.57%	25,527 $2.19 Million
Q1 2019 Nov 18, 2022	BUY	$84.2 - $98.62 $37,469 - $43,885	445 Added 1.71%	26,471 $2.35 Million
Q4 2018 Nov 18, 2022	SELL	$80.14 - $106.07 $104,182 - $137,891	-1,300 Reduced 4.76%	26,026 $2.22 Million
Q3 2018 Nov 18, 2022	SELL	$93.92 - $105.72 $52,595 - $59,203	-560 Reduced 2.01%	27,326 $2.65 Million
Q2 2018 Nov 18, 2022	BUY	$76.01 - $99.03 $721,182 - $939,596	9,488 Added 51.57%	27,886 $2.63 Million
Q1 2018 Nov 18, 2022	SELL	$77.67 - $92.63 $18,563 - $22,138	-239 Reduced 1.28%	18,398 $1.49 Million
Q4 2017 Nov 18, 2022	SELL	$80.76 - $95.13 $68,080 - $80,194	-843 Reduced 4.33%	18,637 $1.66 Million
Q3 2017 Nov 18, 2022	SELL	$80.6 - $94.95 $52,954 - $62,382	-657 Reduced 3.26%	19,480 $1.81 Million
Q2 2017 Nov 18, 2022	BUY	N/A	20,137	20,137 $1.83 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.29 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$931 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$703 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Business Bank, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Business Bank with notifications on news.

Account